Index -
P/E 179.10
EPS (ttm) 1.08
Insider Own 1.92%
Shs Outstand 29.56M
Perf Week 3.53%
Market Cap 5.74B
Forward P/E 96.88
EPS next Y 1.99
Insider Trans -5.85%
Shs Float 29.39M
Perf Month -1.93%
Income 33.05M
PEG -
EPS next Q 0.72
Inst Own 111.40%
Short Float 7.63%
Perf Quarter 7.20%
Sales 755.59M
P/S 7.60
EPS this Y 283.89%
Inst Trans 5.88%
Short Ratio 3.71
Perf Half Y 21.39%
Book/sh 23.25
P/B 8.29
EPS next Y 50.28%
ROA 4.60%
Short Interest 2.24M
Perf Year 33.62%
Cash/sh 13.80
P/C 13.97
EPS next 5Y -
ROE 5.33%
52W Range 123.00 - 257.40
Perf YTD -5.25%
Dividend Est. -
P/FCF 150.25
EPS past 5Y 13.57%
ROI 4.58%
52W High -25.11%
Beta 1.32
Dividend TTM -
Quick Ratio 6.94
Sales past 5Y 66.60%
Gross Margin 84.77%
52W Low 56.72%
ATR (14) 8.96
Dividend Ex-Date -
Current Ratio 7.84
EPS Y/Y TTM 199.09%
Oper. Margin 1.79%
RSI (14) 50.93
Volatility 4.24% 5.05%
Employees 1011
Debt/Eq 0.04
Sales Y/Y TTM 32.52%
Profit Margin 4.37%
Recom 1.65
Target Price 241.50
Option/Short Yes / Yes
LT Debt/Eq 0.04
EPS Q/Q 307.63%
Payout -
Rel Volume 0.44
Prev Close 194.00
Sales Surprise 2.83%
EPS Surprise 875.61%
Sales Q/Q 32.54%
Earnings Nov 04 AMC
Avg Volume 604.55K
Price 192.76
SMA20 1.51%
SMA50 -2.81%
SMA200 3.38%
Trades
Volume 261,447
Change -0.64%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-20-24 Upgrade
BofA Securities
Neutral → Buy
$220 → $255
May-08-24 Downgrade
BofA Securities
Buy → Neutral
$265 → $225
Apr-19-24 Initiated
RBC Capital Mkts
Outperform
$285
Mar-19-24 Initiated
Morgan Stanley
Overweight
$250
Feb-06-24 Resumed
KeyBanc Capital Markets
Overweight
$278
Jan-19-24 Initiated
Jefferies
Buy
$245
Jan-02-24 Downgrade
Stifel
Buy → Hold
$210
Dec-13-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$245 → $187
Jul-19-23 Initiated
Robert W. Baird
Outperform
$371
Apr-14-23 Initiated
Mizuho
Buy
$300
Mar-29-23 Initiated
UBS
Buy
$300
Dec-13-22 Upgrade
Goldman
Neutral → Buy
$245 → $308
Dec-13-22 Initiated
KeyBanc Capital Markets
Overweight
$287
Apr-13-22 Initiated
Truist
Buy
$315
Apr-06-22 Initiated
Wolfe Research
Peer Perform
$270
Mar-02-22 Resumed
BofA Securities
Buy
$270
Jan-04-21 Downgrade
BofA Securities
Buy → Neutral
Dec-15-20 Downgrade
Goldman
Buy → Neutral
$162 → $209
Nov-03-20 Upgrade
Oppenheimer
Underperform → Perform
Nov-03-20 Upgrade
BofA Securities
Neutral → Buy
$125 → $155
Show Previous Ratings
Nov-20-24 02:08PM
Nov-19-24 08:00AM
Nov-18-24 10:00AM
Nov-15-24 08:00AM
Nov-11-24 06:45AM
08:00AM
Loading…
Nov-06-24 08:00AM
06:31AM
Nov-05-24 02:09AM
Nov-04-24 06:30PM
05:20PM
04:02PM
Oct-30-24 09:15AM
08:00AM
Oct-18-24 12:00PM
Oct-11-24 12:15PM
08:00AM
Loading…
Oct-07-24 08:00AM
Oct-04-24 05:04PM
Sep-18-24 09:50AM
Sep-06-24 06:43PM
Sep-02-24 09:50AM
Aug-23-24 07:35AM
Aug-21-24 04:02PM
Aug-09-24 12:20PM
Aug-07-24 10:48AM
Aug-06-24 06:30PM
05:35PM
04:02PM
04:02PM
Aug-05-24 10:10AM
09:16AM
08:00AM
Loading…
Aug-02-24 08:00AM
Jul-29-24 10:59AM
09:21AM
06:45AM
Jul-23-24 08:00AM
Jul-22-24 11:35AM
08:39AM
08:00AM
04:52AM
Jul-19-24 08:00AM
08:00AM
Jul-13-24 08:36AM
Jul-10-24 11:08AM
Jul-09-24 03:17PM
Jul-02-24 08:00AM
Jun-25-24 08:30AM
Jun-24-24 04:10PM
(Investor's Business Daily) -16.72%
02:01PM
10:08AM
(The Wall Street Journal)
Jun-06-24 11:31AM
Jun-04-24 08:00AM
May-28-24 06:00AM
May-23-24 08:00AM
May-21-24 12:40PM
May-09-24 09:35AM
May-08-24 01:49PM
11:33AM
10:16AM
(Thomson Reuters StreetEvents)
09:30AM
07:31AM
May-07-24 08:59PM
05:46PM
05:10PM
04:02PM
May-03-24 09:15AM
Apr-30-24 06:15PM
03:39PM
(Investor's Business Daily)
08:00AM
Apr-26-24 09:14AM
Apr-18-24 12:17PM
02:14AM
Apr-17-24 08:38AM
(The Wall Street Journal) +9.87%
Apr-08-24 05:17AM
Apr-02-24 08:00AM
Mar-27-24 07:00PM
Mar-21-24 02:31AM
Mar-18-24 12:01PM
Mar-14-24 01:49AM
Mar-05-24 08:00AM
Feb-13-24 09:02AM
05:45AM
Feb-07-24 11:33AM
(Thomson Reuters StreetEvents) -10.55%
11:15AM
10:02AM
Feb-06-24 06:30PM
05:35PM
04:35PM
04:02PM
Feb-05-24 08:00AM
Feb-04-24 06:56AM
Feb-01-24 06:55AM
Jan-30-24 10:00AM
Jan-26-24 08:00AM
Jan-24-24 10:15AM
Jan-19-24 01:12AM
Jan-10-24 10:45AM
Jan-09-24 10:39AM
08:00AM
Jan-08-24 08:00AM
Jan-05-24 01:07PM
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Rondoni John Chief Technology Officer Nov 01 '24 Option Exercise 61.38 8,703 534,219 20,051 Nov 05 04:01 PM Rondoni John Chief Technology Officer Nov 01 '24 Sale 193.47 8,703 1,683,731 11,348 Nov 05 04:01 PM JOHN RONDONI Officer Nov 01 '24 Proposed Sale 193.46 8,703 1,683,723 Nov 01 04:47 PM Ebeling Philip Officer Sep 11 '24 Proposed Sale 247.28 5,453 1,348,445 Sep 11 06:01 PM McCormick Shawn Director Sep 09 '24 Sale 220.00 800 176,000 23,140 Sep 11 05:02 PM Rondoni John Chief Technology Officer Sep 09 '24 Sale 215.00 31 6,665 11,348 Sep 11 05:01 PM SHAWN T MCCORMICK Director Sep 09 '24 Proposed Sale 220.00 800 176,000 Sep 09 04:09 PM JOHN RONDONI Officer Sep 09 '24 Proposed Sale 215.00 31 6,665 Sep 09 04:08 PM Rondoni John Chief Technology Officer Aug 22 '24 Option Exercise 71.00 5,000 355,000 16,379 Aug 23 04:09 PM Rondoni John Chief Technology Officer Aug 22 '24 Sale 189.83 5,000 949,143 11,379 Aug 23 04:09 PM JOHN RONDONI Officer Aug 22 '24 Proposed Sale 189.82 5,000 949,100 Aug 22 04:22 PM Ban Randy Chief Commercial Officer Aug 15 '24 Option Exercise 42.15 16,139 680,259 19,195 Aug 19 08:14 PM Ban Randy Chief Commercial Officer Aug 16 '24 Option Exercise 42.15 4,861 204,891 7,917 Aug 19 08:14 PM Ban Randy Chief Commercial Officer Aug 15 '24 Sale 193.10 16,139 3,116,397 3,056 Aug 19 08:14 PM Ban Randy Chief Commercial Officer Aug 16 '24 Sale 188.55 4,861 916,549 3,056 Aug 19 08:14 PM RANDALL A BAN Officer Aug 16 '24 Proposed Sale 188.55 4,861 916,560 Aug 16 04:34 PM Ebeling Philip Officer Aug 15 '24 Proposed Sale 194.84 43,901 8,553,615 Aug 15 05:36 PM McCormick Shawn Director Aug 14 '24 Option Exercise 0.94 8,537 8,025 23,940 Aug 15 04:19 PM RANDALL A BAN Officer Aug 15 '24 Proposed Sale 193.10 16,139 3,116,380 Aug 15 04:13 PM Ebeling Philip Officer Aug 14 '24 Proposed Sale 190.03 4,596 873,393 Aug 14 04:50 PM Griffin Jerry C Director Jul 26 '24 Proposed Sale 126.53 5,952 753,086 Jul 26 05:02 PM McCormick Shawn Director May 10 '24 Option Exercise 0.94 2,500 2,350 15,403 May 13 04:30 PM NELSON MARILYN C Director Apr 29 '24 Option Exercise 240.68 1,175 282,799 35,620 May 01 04:01 PM Buchholz Richard Chief Financial Officer Apr 17 '24 Sale 230.03 15,000 3,450,450 28,271 Apr 18 04:44 PM Herbert Timothy P. CEO and President Apr 01 '24 Sale 205.09 40,000 8,203,581 63,658 Apr 03 07:44 PM Griffin Jerry C Director Apr 01 '24 Option Exercise 16.00 296 4,736 10,932 Apr 03 04:55 PM Griffin Jerry C Director Apr 01 '24 Sale 213.99 32 6,848 10,900 Apr 03 04:55 PM NELSON MARILYN C Director Apr 01 '24 Option Exercise 16.00 3,273 52,368 34,338 Apr 02 08:29 PM NELSON MARILYN C Director Mar 27 '24 Option Exercise 90.85 3,243 294,633 31,065 Mar 29 04:49 PM Griffin Jerry C Director Mar 25 '24 Option Exercise 16.00 1,000 16,000 11,190 Mar 27 04:01 PM Griffin Jerry C Director Mar 25 '24 Sale 197.81 554 109,587 10,636 Mar 27 04:01 PM Rondoni John Chief Technology Officer Mar 22 '24 Sale 194.40 4,387 852,849 11,270 Mar 26 08:23 PM Griffin Jerry C Director Mar 18 '24 Option Exercise 16.00 1,000 16,000 10,744 Mar 20 05:51 PM Griffin Jerry C Director Mar 18 '24 Sale 193.53 554 107,216 10,190 Mar 20 05:51 PM Griffin Jerry C Director Mar 11 '24 Option Exercise 16.00 1,000 16,000 10,298 Mar 13 09:21 PM Griffin Jerry C Director Mar 11 '24 Sale 198.05 554 109,720 9,744 Mar 13 09:21 PM Griffin Jerry C Director Mar 01 '24 Option Exercise 16.00 1,000 16,000 9,852 Mar 05 05:08 PM Griffin Jerry C Director Mar 01 '24 Sale 179.44 554 99,410 8,298 Mar 05 05:08 PM NELSON MARILYN C Director Mar 01 '24 Option Exercise 0.94 2,555 2,402 27,822 Mar 05 05:06 PM Rondoni John Chief Technology Officer Feb 29 '24 Sale 179.25 8,605 1,542,441 15,657 Mar 04 06:21 PM Ban Randy Chief Commercial Officer Feb 27 '24 Option Exercise 42.15 3,060 128,979 6,089 Feb 27 08:39 PM Ban Randy Chief Commercial Officer Feb 23 '24 Option Exercise 4.11 12,230 50,234 15,259 Feb 27 08:39 PM Ban Randy Chief Commercial Officer Feb 23 '24 Sale 185.37 12,230 2,267,075 3,029 Feb 27 08:39 PM Ban Randy Chief Commercial Officer Feb 27 '24 Sale 182.01 3,060 556,951 3,029 Feb 27 08:39 PM Rondoni John Chief Technology Officer Feb 15 '24 Option Exercise 2.07 8,000 16,560 24,262 Feb 16 04:05 PM NELSON MARILYN C Director Feb 09 '24 Option Exercise 0.94 4,000 3,760 25,267 Feb 13 04:01 PM Jandrich Steven VP, Human Resources Jan 30 '24 Option Exercise 0.94 16,225 15,252 23,096 Jan 31 08:40 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite